Page last updated: 2024-08-24

xemilofiban and Blood Loss, Postoperative

xemilofiban has been researched along with Blood Loss, Postoperative in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Boersma, E; Brugts, JJ; Guarneri, M; Hu, S; Mercado, N; O'Neill, WW; Price, M; Schatz, R; Serruys, PW; Teirstein, P; Wijns, W	1

Trials

1 trial(s) available for xemilofiban and Blood Loss, Postoperative

Article	Year
Relation of periprocedural bleeding complications and long-term outcome in patients undergoing percutaneous coronary revascularization (from the Evaluation of Oral Xemilofiban in Controlling Thrombotic Events [EXCITE] Trial). The American journal of cardiology, 2009, Apr-01, Volume: 103, Issue:7 Topics: Administration, Oral; Angioplasty, Balloon, Coronary; Benzamidines; Coronary Angiography; Coronary Artery Disease; Coronary Thrombosis; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Preoperative Care; Risk Factors; Survival Rate; Thrombocytopenia; Time Factors; Treatment Outcome; United States	2009

Article

Year

Relation of periprocedural bleeding complications and long-term outcome in patients undergoing percutaneous coronary revascularization (from the Evaluation of Oral Xemilofiban in Controlling Thrombotic Events [EXCITE] Trial).

The American journal of cardiology, 2009, Apr-01, Volume: 103, Issue:7

Topics: Administration, Oral; Angioplasty, Balloon, Coronary; Benzamidines; Coronary Angiography; Coronary Artery Disease; Coronary Thrombosis; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Preoperative Care; Risk Factors; Survival Rate; Thrombocytopenia; Time Factors; Treatment Outcome; United States

2009